BICYCLE THERAPEUTICS PLC

By person

34 insiders · 260 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BAKER BROS. ADVISORS LP entity

Director

$21.23M (10)

—

+$21.23M

10,018,674

14.35%

$43.18M

+64.8%

Legault Pierre

Director

—

$10.04M (10) scheduled

−$10.04M

46,000

0.0659%

$198.26K

—

Lee Kevin

CHIEF EXECUTIVE OFFICER

—

$9.62M (71) scheduled

−$9.62M

603,671

0.8647%

$2.60M

+119.4%

NG CAROLYN

Director

$8.00M (1)

—

+$8.00M

2,192,597

3.14%

$9.45M

—

SVLSF V, LLC entity

10% owner

$5.40M (2)

—

+$5.40M

1,915,274

2.74%

$8.25M

—

HARLAND DEBORAH

Director

$5.40M (1)

—

+$5.40M

1,915,275

2.74%

$8.25M

—

GSK plc entity

10% owner

$5.40M (1)

$91.83K (3)

+$5.31M

1,910,531

2.74%

$8.23M

—

TYBOURNE CAPITAL MANAGEMENT (HK) LTD entity

10% owner

$5.10M (1)

—

+$5.10M

1,957,961

2.80%

$8.44M

—

Anstey Michael

Director

$4.40M (1)

—

+$4.40M

1,751,437

2.51%

$7.55M

—

Cambridge Innovation Capital (Jersey) Ltd entity

10% owner

$4.40M (1)

—

+$4.40M

1,751,437

2.51%

$7.55M

—

BINGHAM KATE

Director

$5.40M (2)

$1.53M (4)

+$3.87M

1,910,016

2.74%

$8.23M

+4,719%

Crockett Nigel

CHIEF BUSINESS OFFICER

—

$2.83M (14) scheduled

−$2.83M

51,053

0.0731%

$220.04K

—

Kalowski Lee

President and CFO

—

$2.82M (16) scheduled

−$2.82M

30,309

0.0434%

$130.63K

—

Novartis Bioventures Ltd entity

10% owner

$2.36M (1)

—

+$2.36M

1,769,641

2.53%

$7.63M

—

Keen Nicholas

CHIEF SCIENTIFIC OFFICER

—

$1.86M (17)

−$1.86M

62,024

0.0888%

$267.32K

+50.1%

Milnes Alistair

CHIEF OPERATING OFFICER

—

$364.03K (18)

−$364.03K

136,717

0.1958%

$589.25K

+5,780%

Skynner Michael

CHIEF SCIENTIFIC OFFICER

—

$358.06K (22)

−$358.06K

157,171

0.2251%

$677.41K

+282.2%

Thompson Travis Alvin

Chief Financial Officer

—

$279.48K (27) scheduled

−$279.48K

64,441

0.0923%

$277.74K

+696.2%

Hannay Michael Charles Ferguson

CHIEF PROD & SUPPLY CHAIN OFF

—

$113.88K (17)

−$113.88K

94,375

0.1352%

$406.76K

+307.7%

Young Alethia

Chief Financial Officer

—

$77.42K (8) scheduled

−$77.42K

87,081

0.1247%

$375.32K

—

Arroyo Santiago

CHIEF DEVELOPMENT OFFICER

—

$69.65K (1)

−$69.65K

69,057

0.0989%

$297.64K

—

Smethurst Dominic

Chief Medical Officer

—

$52.34K (1)

−$52.34K

36,699

0.0526%

$158.17K

—

Perry Jennifer Scott

Chief Operating Officer

—

$13.02K (6) scheduled

−$13.02K

91,052

0.1304%

$392.43K

−3.0%

Swanton Robert Charles

Director

—

$872.10 (1) scheduled

−$872.10

19,213

0.0275%

$82.81K

+522.0%

Vertex Global Healthcare Fund I Pte Ltd. entity

10% owner

—

1,621,168

2.32%

$6.99M

—

Winter Gregory Paul

Director

—

196,427

0.2814%

$846.60K

+296.0%

Gutierrez-Ramos Jose-Carlos

Director

—

32,500

0.0466%

$140.08K

—

Bourque Janice

Director

—

32,500

0.0466%

$140.08K

—

Sands Stephen H.

Director

—

26,893

0.0385%

$115.91K

—

Kender Richard N

Director

—

23,000

0.0329%

$99.13K

—

Riva Alessandro

Director

—

19,880

0.0285%

$85.68K

—

Jordan Veronica GH

Director

—

16,750

0.0240%

$72.19K

—

Hoppenot Herve

Director

—

15,532

0.0222%

$66.94K

—

DANSEY ROGER D

Director

—

15,532

0.0222%

$66.94K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

BAKER BROS. ADVISORS LP

16 Dec 2024

Director

Buy indirect

457,631

$15.34

$7.02M

BAKER BROS. ADVISORS LP

16 Dec 2024

Director

Buy indirect

42,369

$15.34

$650.02K

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

566,814

$13.80

$7.82M

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

52,656

$13.80

$726.86K

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

244,587

$13.72

$3.36M

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

22,722

$13.72

$311.84K

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

59,995

$13.63

$817.66K

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

5,573

$13.63

$75.95K

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

30,241

$13.50

$408.19K

BAKER BROS. ADVISORS LP

13 Dec 2024

Director

Buy indirect

2,809

$13.50

$37.92K

Cambridge Innovation Capital (Jersey) Ltd

29 May 2019

10% owner

Buy

314,286

$14.00

$4.40M

Showing 250 of 260 transactions. The figures above use every one of them.

BICYCLE THERAPEUTICS PLC

By person

Individual transactions

What was left out